Media Room
Fourth Quarter & Full Year 2025 Results
Fourth quarter and full year 2025 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Press Releases
February 3, 2026
Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion
February 2, 2026
Press Release: Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease
January 30, 2026
Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
July 2025
Half-year Financial Reports
Half Year 2025 Financial Report
July 2025
Half-year Financial Reports
Half year 2025 financial report XBRL package
September 2024
Annual Report on Form 20-F
Annual Report on Form 20-F 2024
July 2024
Half-year Financial Reports
Half Year 2024 Financial Report